TriSalus Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TriSalus Life Sciences, Inc. (TLSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.28 million shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-08-12
- TriSalus Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 125.00K shares.
- TriSalus Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 1.16M shares, a 12.06% decline year-over-year.
- TriSalus Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 350.29K shares.
- TriSalus Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was -8.48K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2025-06-30 | 125.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 1.28M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 1.16M shares 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | 350.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 341.81K shares derived: sum of 2 quarters · filed 2024-11-14 | 1.66M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | -8.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 1.31M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 1.32M shares 10-Q · filed 2024-05-15 | ||
| 2023-09-30 | 1.18M shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |